Hyperuricemia: Symptoms, Causes, and Management

Hyperuricemia (serum urate >6.8 mg/dL, saturation point) can lead to multiple clinical consequences.

Clinical Manifestations

  • Gout: MSU crystal deposition in joints → acute flares (1st MTP classic), chronic tophi, joint destruction; most common manifestation
  • Uric Acid Nephrolithiasis: Kidney stones (radiolucent); obstructive uropathy
  • Chronic Kidney Disease: Crystal deposition, tubulointerstitial inflammation, vascular changes; bidirectional with hyperuricemia
  • Cardiovascular Association: Hypertension, coronary disease, heart failure, stroke — independent risk factor debated; likely mediated by inflammation, endothelial dysfunction, RAAS activation
  • Metabolic Syndrome: Clusters with obesity, insulin resistance, dyslipidemia, hypertension
  • Oxidative Stress Paradox: Urate is antioxidant at normal levels; pro-oxidant at high concentrations via NADPH oxidase activation

Causes

  • Decreased Excretion (90%): Renal underexcretion (genetic, drugs: diuretics, cyclosporine, pyrazinamide, low-dose aspirin), metabolic acidosis, renal insufficiency
  • Increased Production (10%): High purine intake, tumor lysis, myeloproliferative disorders, Lesch-Nyhan, glycogen storage diseases
  • Mixed: Alcohol (especially beer), fructose-sweetened beverages, obesity

Management

  • Asymptomatic Hyperuricemia: Generally not treated (except very high >12 mg/dL, transplant, tumor lysis prophylaxis); lifestyle modification
  • Gout: Acute: NSAIDs, colchicine, glucocorticoids; Chronic: ULT (allopurinol, febuxostat) to target <6 mg/dL (<5 mg/dL if tophi)
  • Stones/CKD: Hydration, alkalinization, ULT consideration
  • Lifestyle: Low-purine diet, limit alcohol/fructose, weight loss, hydration, dairy/vitamin C (uricosuric)

Treat the patient, not the number—target therapy to clinical manifestations and risk profile.

Urinary Disorders - Related Articles